New Opportunities for Health Technology Developers under EU HTA Regulation

The European Commission has announced the opening of the new Joint Scientific Consultations (JSCs) periods under EU Health Technology Assessment (HTA) Regulation (Regulation (EU) 2021/2282) (sourced link). JSCs enable health technology developers to obtain coordinated, EU-level feedback while planning clinical studies, focused on the evidence needs for a potential future Joint Clinical Assessment (JCA). JSCs… Read more »

Read more